Impaired FGFR1/β-Klotho signaling, as observed in obesity, diminishes FGF21 responsiveness, whereas pharmacological activation of this pathway restores thermogenic capacity through UCP1 induction. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.